NCT06082947: An ongoing trial by Nationwide Children's Hospital
This trial is ongoing. It must report results 4 years, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06082947 |
|---|---|
| Title | αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) for Children and Young Adults With Hematologic Malignancies |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 18, 2023 |
| Completion date | Dec. 1, 2028 |
| Required reporting date | Dec. 1, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |